Kaplan-Meier analysis was used to demonstrate the relationship between CRTC2 expression and overall survival, confirming that ovarian cancer with high CRTC2 expression had a shorter overall survival, while ovarian cancer with low CRTC2 expression had a longer overall survival (p < 0.001) (Figure 3B). This evidence concerns the gene CRTC2 and ovarian cancer.